Search Results - "Mazzarol, G."

Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors by Cocorocchio, E., Martinoli, C., Gandini, S., Pala, L., Conforti, F., Stucchi, S., Mazzarol, G., Ferrucci, P.

“…Purpose The aim of this study is to verify if baseline hematological markers, in patients with advanced melanoma receiving BRAF inhibitor (BRAFi)-based…”
Get full text

Long-term oncological results of breast conservative treatment with oncoplastic surgery by Rietjens, M, Urban, C.A, Rey, P.C, Mazzarol, G, Maisonneuve, P, Garusi, C, Intra, M, Yamaguchi, S, Kaur, N, De Lorenzi, F, Matthes, A.G.Z, Zurrida, S, Petit, J.Y

“…Summary Oncoplastic surgery combining breast conservative treatment (BCT) and plastic surgery techniques may allow more extensive breast resections and improve…”
Get full text

Dual regulation of Myc by Abl by Sanchez-Arévalo Lobo, V J, Doni, M, Verrecchia, A, Sanulli, S, Fagà, G, Piontini, A, Bianchi, M, Conacci-Sorrell, M, Mazzarol, G, Peg, V, Losa, J H, Ronchi, P, Ponzoni, M, Eisenman, R N, Doglioni, C, Amati, B

“…The tyrosine kinase c-Abl (or Abl) and the prolyl-isomerase Pin1 cooperatively activate the transcription factor p73 by enhancing recruitment of the…”
Get full text

Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure by Montagna, E, Viale, G, Rotmensz, N, Maisonneuve, P, Galimberti, V, Luini, A, Intra, M, Veronesi, P, Mazzarol, G, Pruneri, G, Renne, G, Torrisi, R, Cardillo, A, Cancello, G, Goldhirsch, A, Colleoni, M

“…It is still controversial whether the identification of micrometastases and isolated tumor cells in the axillary lymph nodes of patients with breast cancer has…”
Get full text

Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result by Rastrelli, M, Soteldo, J, Zonta, M, Trifirò, G, Mazzarol, G, Vitali, G C, Mosconi, M, Testori, A

“…Certain patients with squamous cell carcinoma (SCC) have much higher rates of regional nodal metastases than is often reported. This study aims to further…”
Get more information

1441 POSTER Prognostic Factors and Patterns of Recurrence After Resection of Primary Desmoids – a Single-institution Experience Over 10 Years by Bertani, E, Chiappa, A, Testori, A, Misitano, P, Mazzarol, G, Botteri, E, Biffi, R, Andreoni, B

Get full text

Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options by Gentilini, O., Masullo, M., Rotmensz, N., Peccatori, F., Mazzarol, G., Smeets, A., Simsek, S., De Dosso, S., Veronesi, P., Intra, M., Zurrida, S., Viale, G., Goldhirsch, A., Veronesi, U.

“…Assessment of biological features and treatment of patients with breast cancer presenting during pregnancy or lactation. Immunohistochemical analysis of…”
Get full text

Factors Affecting Recurrence After Radical Surgery for Primary Desmoid Tumors. A Single-Centre Experience Over 10 Years by Bertani, E, Chiappa, A, Testori, A, Misitano, G. Mazzarol, P, Botteri, E, Biffi, R, Branchi, V, Uccelli, F, Andreoni, B

Get full text

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors by Colleoni, M., Minchella, I., Mazzarol, G., Nolè, F., Peruzzotti, G., Rocca, A., Viale, G., Orlando, L., Ferretti, G., Curigliano, G., Veronesi, P., Intra, M., Goldhirsch, A.

“…Background We recently demonstrated that in premenopausal patients with estrogen receptors (ER)-absent tumors, early initiation of systemic chemotherapy after…”
Get full text

Sentinel node biopsy in head and neck cancer by Mozzillo, N, Chiesa, F, Botti, G, Caracò, C, Lastoria, S, Giugliano, G, Mazzarol, G, Paganelli, G, Ionna, F

“…The purpose of this study was to assess the value of sentinel node (SN) biopsy in oral cancer by means of a lymphoscintigraphic technique and intraoperative…”
Get full text

P81 Cutaneous melanoma in the elderly by Testori, A, Soteldo, J, Sances, D, Mazzarol, G, Trifirò, G, Verrecchia, F

Get full text

Aggressive digital papillary adenocarcinoma by Rastrelli, M, Soteldo, J, Vitali, G C, Mazzarol, G, Trifiro, G, Tosti, G, Testori, A

Get full text

6627 Minimizing recurrence for desmoid tumours of the anterior abdominal wall: a five-years follow-up monocentric series by Bertani, E, Chiappa, A.C, Mazzarol, G, Testori, A, Contino, G, Barsalini, C, Andreoni, B

Get full text

Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas by VERGANI, V, GAROFALO, A, TARABOLETTI, G, BANI, M. R, BORSOTTI, P, PARKER, M. Pelina, DRUDIS, T, MAZZAROL, G, VIALE, G, GIAVAZZI, R, STETLER-STEVENSON, W. G

“…Inhibitors of proteases prevent tumor-associated matrix degradation, affecting tumor growth, angiogenesis and metastasis. Our study was designed to investigate…”
Get full text

CDX-2 should be included in the work-up of patients with lung metastases from unknown primary by Fazio, N., De Pas, T., de Braud, F., Spaggiari, L., Mazzarol, G., Biffi, R., Andreoni, B., Zampino, M., Curigliano, G., Lorizzo, K., Di Meglio, G., Goldhirsch, A.

Get full text

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase by Colleoni, M., Curigliano, G., Minchella, I., Peruzzotti, G., Nolè, F., Mazzarol, G., Renne, G., Orlando, L., Rocca, A., Veronesi, P., Intra, M., Viale, G., Sandri, M. T., Severi, G., Goldhirsch, A.

“…Background: Experimental data on perioperative chemotherapy (PeCT) indicate that its initiation might be most useful if administered as close as possible to…”
Get full text

Huge malignant localized fibrous tumor of the pleura by Veronesi, G, Spaggiari, L, Mazzarol, G, De Pas, M, Leo, F, Solli, P, Pastorino, U

“…Localized fibrous tumor is an unfrequent mesenchymal neoplasm. The malignant variant of the pleura is exceptional and differential diagnosis with the more…”
Get full text

1072P Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome by Cocorocchio, E., Nezi, L., Gandini, S., Manzo, T., Mazzarella, L., Lotti, F., Pala, L., Gnagnarella, P., Conforti, F., Pennacchioli, E., Fierro, M.T., Ribero, S., Senetta, R., Picciotto, F., Caliendo, V., Quaglino, P., Mazzarol, G., Orsolini, G.M., Prestianni, P., Ferrucci, P.F.

Get full text

1147P Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in locally advanced or oligometastatic melanoma: Preliminary results by Cocorocchio, E., Pala, L., Nezi, L., Manzo, T., Mazzarella, L., Fiorenza, L., Gandini, S., Conforti, F., Mazzarol, G., Queirolo, P., Pennacchioli, E., Orsolini, G.M., Fierro, M.T., Ribero, S., Senetta, R., Fava, P., Picciotto, F., Caliendo, V., Quaglino, P., Ferrucci, P.F.

Get full text

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay by Curigliano, G., Colleoni, M., Renne, G., Mazzarol, G., Gennari, R., Peruzzotti, G., de Braud, F., Robertson, C., Maiorano, E., Veronesi, P., Nolè, F., Mandalà, M., Ferretti, G., Viale, G., Goldhirsch, A.

“…Background Male breast cancer (MBC) is an uncommon disease, and most of our current knowledge of its biology, natural history and treatment has been…”
Get full text